信息搜索
信息关键字：证
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265]

·绿色新材拟向银行申请2000万综合授信朱士荣提供个人无限连带责任保证担保2023-1-12 1:04:39
·国文股份全资子公司取得2项实用新型专利证书2023-1-12 0:32:50
·弘森药业向江苏证监局报送了向不特定合格投资者公开发行股票并在北京证券交易所上市辅导备案材料2023-1-11 23:43:32
·钢研功能拟向银行申请5000万授信李博及配偶刘琼提供个人连带责任保证担保2023-1-11 22:05:15
·钢研功能拟购买西安阎良国家航空高技术产业基地凌飞路以南、云光路以西地块土地使用权竞买保证金580万2023-1-11 21:56:32
·兴证策略：三年之后外资或再度成为主要矛盾2023-1-11 20:51:51
·兴证策略：三年之后，A股外资或再度成为主要矛盾2023-1-11 17:55:45
·进一步丰富产品线华海药业非洛地平缓释片获药品注册证书2023-1-11 17:17:49
·维力医疗：子公司取得医疗器械注册证2023-1-11 16:31:35
·国家移民管理局：即日起对日韩公民暂停签发口岸签证2023-1-11 16:31:24
·国家移民管理局暂停签发韩国、日本公民来华口岸签证及72/144小时过境免签-财经2023-1-11 15:20:38
·国家移民管理局暂停签发韩国、日本公民来华口岸签证及72/144小时过境免签2023-1-11 15:11:00
·美股三大指数收涨，热门中概股普涨；中国驻日本使领馆暂停审发日本公民赴华普通签证2023-1-11 9:33:33
·东北证券邓利军：消费赔率与胜率较高 低位布局正当时2023-1-11 9:24:19
·中国暂停日本公民赴华普通签证；杭州市委书记调研蚂蚁集团…重要消息还有这些2023-1-11 8:30:47
·年度首家券商换帅！苏军良接任华福证券党委书记，曾在兴业银行工作30年2023-1-11 8:26:42
·突发！日本公民赴华普通签证，暂停审发；监管出手！两人被罚没845万；辉瑞：允许中国强仿Paxlovid消息不实2023-1-11 6:32:23
·1月11日国内四大证券报纸、重要财经媒体头版头条内容精华摘要2023-1-11 6:11:28
·证监会出手！这A股及实控人被立案调查2023-1-11 2:18:08
·格林司通向中国证券监督管理委员会江苏监管局报送了辅导备案申请材料2023-1-11 0:45:06

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265]